Bulder, I.
21  Ergebnisse:
Personensuche X
?
1

Diabetes‐independent increase of factor VII‐activating prot..:

de Jong, H.K. ; Koh, G.C.K.W. ; Bulder, I....
Journal of Thrombosis and Haemostasis.  13 (2015)  1 - p. 41-46 , 2015
 
?
2

Tissue factor pathway inhibitor is an inhibitor of factor V..:

STEPHAN, F. ; Dienava-Verdoold, I. ; BULDER, I....
Journal of Thrombosis and Haemostasis.  10 (2012)  6 - p. 1165-1171 , 2012
 
?
 
?
5

Activation of factor VII-activating protease in human infla..:

Stephan, F ; Hazelzet, Jan ; Bulder, I...
Stephan , F , Hazelzet , J , Bulder , I , Boermeester , MA , van Till , JWO , van der Poll , T , Wuillemin , WA , Aarden , LA & Zeerleder , S 2011 , ' Activation of factor VII-activating protease in human inflammation: a sensor for cell death ' , Critical Care , vol. 15 , pp. R110 . https://doi.org/10.1186/cc10131.  , 2011
 
?
6

Production, purification and characterisation of recombinan..:

de Bruin, E.C ; Roem, D ; Bulder, I...
de Bruin , E C , Roem , D , Bulder , I , Dieker , M , Voerman , G & Hack , C E 2005 , ' Production, purification and characterisation of recombinant Fahsin, a novel antistasin-type proteinase inhibitor ' , FEMS Yeast Research , vol. 5 , no. 11 , pp. 1069-1077 . https://doi.org/10.1016/j.femsyr.2005.03.005.  , 2005
 
?
 
?
10

Review of health safety aspects of nanotechnologies in food..:

Bouwmeester, Hans ; Dekkers, Susan ; Noordam, Maryvon Y....
Regulatory Toxicology and Pharmacology.  53 (2009)  1 - p. 52-62 , 2009
 
?
 
?
12

Invited perspectives: A research agenda towards disaster ri..:

Ward, P.J ; Daniell, J ; Duncan, M...
info:eu-repo/grantAgreement/EC/H2020/101003276/.  , 2022
 
?
13

Invited perspectives: A research agenda towards disaster ri..:

Ward, P.J ; Daniell, J ; Duncan, M...
https://pure.iiasa.ac.at/id/eprint/18022/1/nhess-22-1487-2022.pdf.  , 2022
 
?
14

Invited perspectives: A research agenda towards disaster ri..:

Ward, P.J ; Daniell, J ; Duncan, M...
http://pure.iiasa.ac.at/id/eprint/18022/1/nhess-22-1487-2022.pdf.  , 2022
 
1-15